Gerald Cagle, Ph.D. has served as a member of the Eyevensys Board since 2017 and was appointed Board Chair in January, 2020. He worked in Alcon’s Research & Development for..
Johannes has been an investment manager at the Boehringer Ingelheim (BI) Venture Fund (BIVF) since May 2019, and serves as a director at AgomAb Therapeutics in Gent..
Dominik is a founding partner of BB Pureos Bioventures. He is also President of the Swiss Biotech Association and a co-founder and Executive Chairman of CDR-Life. Previously..
Neena is Director of Science at Quark Venture, which she joined in 2017. Previously, Neena was the director of strategic partnerships at QB3 at the California Institute..
Ohad has been a biotech analyst at Pontifax for 8 years. He is involved in identifying and evaluating new investment opportunities. Ohad focuses on early-stage projects and oversees..
Chahra is the Investment Director and head of the fund for biotherapies and rare diseases at Bpifrance, which she joined in 2001. She is also Vice President of the Supervisory Board..
François is Venture Partner at Sofimac Innovation in Paris. A medical oncologist by training, he has spent his career in executive management with Big Pharma and biotech in research..
Catherine is a Partner at Cap Decisif, a Paris-based seed Fund, which she joined in 2003. She is also a Board Director at Axess Vision Technology, EyeBrain, Innavirvax..